Detalles de la búsqueda
1.
The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
Int J Cancer;
154(4): 692-700, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37818966
2.
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Oncologist;
28(10): 875-884, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676712
3.
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study.
Neoplasma;
70(1): 158-165, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36620878
4.
The predictive value of vitamin D follow-up and supplementation on recurrence in patients with colorectal cancer.
Future Oncol;
18(18): 2247-2256, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35469444
5.
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.
Future Oncol;
18(23): 2573-2582, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734870
6.
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.
Int J Gynecol Cancer;
32(4): 502-507, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35086927
7.
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Turk J Med Sci;
52(4): 1022-1032, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36326360
8.
Prognostic significance of 68 Ga-FAPI PET/CT in patients with bone metastases in various cancers.
Ann Nucl Med;
2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38684594
9.
Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study.
Expert Opin Pharmacother;
25(4): 477-484, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38568074
10.
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma.
J Immunother;
47(5): 182-189, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38333962
11.
The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment Characteristics of Operated Lung Cancer Patients.
J Coll Physicians Surg Pak;
33(11): 1271-1277, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37926880
12.
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.
J Cancer Res Clin Oncol;
149(2): 865-875, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35381885
13.
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study).
J Cancer Res Clin Oncol;
149(8): 4141-4148, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36048274
14.
Prognostic and Predictive Significance of PD-L1 Expression in Non-Small Cell Lung Cancer Patients: A Single-Center Experience.
Turk Patoloji Derg;
37(3): 239-248, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34514576
Resultados
1 -
14
de 14
1
Próxima >
>>